Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Genome Engineering

Lorenz Mayr's Biography

Lorenz Mayr, Vice President, AstraZeneca Ltd

Lorenz is working as Vice President, Reagents & Assay Development with global responsibility for generation of biological reagents and assay development activities at AstraZeneca. This includes generation of proteins and cell lines for hit finding, hit-to-lead and lead optimisation activities including structure & biophysics for all therapeutic areas, generation of tool antibodies, transgenic animals, stem/primary cells as tools for target validation and lead optimisation. His department is responsible for the development of biochemical, cell-based and phenotypic assays at AstraZeneca.
Before that, he was working as Executive Director at Novartis in Basel/Switzerland, at Bayer in Leverkusen & Wuppertal/Germany and at the MIT/Whitehead Institute in Cambridge/MA (U.S.A.).
He has published more than 50 papers in peer-reviewed journals and serves on several editorial and scientific advisory boards, including two terms at the Board of Directors for SBS (2004-2011) and has been working as the Conference Chair of the MipTec Conference, Europe’s largest drug discovery event.

Lorenz Mayr Image

Working Together to Unlock the Potential of Precise Genome Editing

Wednesday, 7 October 2015 at 14:45

Add to Calendar ▼2015-10-07 14:45:002015-10-07 15:45:00Europe/LondonWorking Together to Unlock the Potential of Precise Genome EditingGenome Engineering in Hanover, GermanyHanover,

We will present AstraZeneca’s activities with the CRISPR/Cas9 technology for target discovery, target validation & mechanistic studies and will review our external academic and industrial research collaborations for genome-wide target discovery.

Add to Calendar ▼2015-10-07 00:00:002015-10-08 00:00:00Europe/LondonGenome EngineeringGenome Engineering in Hanover, GermanyHanover,